CA2084894A1 - Detection specifique du mycobacterium tuberculosis - Google Patents
Detection specifique du mycobacterium tuberculosisInfo
- Publication number
- CA2084894A1 CA2084894A1 CA002084894A CA2084894A CA2084894A1 CA 2084894 A1 CA2084894 A1 CA 2084894A1 CA 002084894 A CA002084894 A CA 002084894A CA 2084894 A CA2084894 A CA 2084894A CA 2084894 A1 CA2084894 A1 CA 2084894A1
- Authority
- CA
- Canada
- Prior art keywords
- sequence
- sequences
- dna
- tuberculosis
- primers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000187479 Mycobacterium tuberculosis Species 0.000 title claims abstract description 9
- 238000011895 specific detection Methods 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 17
- 230000000295 complement effect Effects 0.000 claims abstract description 7
- 201000008827 tuberculosis Diseases 0.000 claims description 35
- 108020004414 DNA Proteins 0.000 claims description 34
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 31
- 230000003321 amplification Effects 0.000 claims description 30
- 239000012634 fragment Substances 0.000 claims description 27
- 239000000523 sample Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 19
- 239000012472 biological sample Substances 0.000 claims description 18
- 238000009396 hybridization Methods 0.000 claims description 16
- 239000013612 plasmid Substances 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 238000012795 verification Methods 0.000 claims description 8
- 241000186359 Mycobacterium Species 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 6
- 230000004544 DNA amplification Effects 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 238000001502 gel electrophoresis Methods 0.000 claims description 3
- 239000002853 nucleic acid probe Substances 0.000 claims description 3
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 239000013615 primer Substances 0.000 description 43
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000186366 Mycobacterium bovis Species 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 241000186367 Mycobacterium avium Species 0.000 description 3
- 241000187919 Mycobacterium microti Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 2
- 241000187490 Mycobacterium scrofulaceum Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241001379910 Ephemera danica Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062207 Mycobacterial infection Diseases 0.000 description 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 102000008579 Transposases Human genes 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9007192 | 1990-06-08 | ||
| FR9007192A FR2663033B1 (fr) | 1990-06-08 | 1990-06-08 | Detection specifique du mycobacterium tuberculosis. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2084894A1 true CA2084894A1 (fr) | 1991-12-09 |
Family
ID=9397443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002084894A Abandoned CA2084894A1 (fr) | 1990-06-08 | 1991-06-07 | Detection specifique du mycobacterium tuberculosis |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0461045B1 (enExample) |
| JP (1) | JPH05507617A (enExample) |
| AT (1) | ATE142702T1 (enExample) |
| CA (1) | CA2084894A1 (enExample) |
| DE (1) | DE69121975T2 (enExample) |
| DK (1) | DK0461045T3 (enExample) |
| ES (1) | ES2093688T3 (enExample) |
| FR (1) | FR2663033B1 (enExample) |
| GR (1) | GR3021781T3 (enExample) |
| HK (1) | HK1000072A1 (enExample) |
| WO (1) | WO1991019004A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2020958C (en) * | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5766849A (en) * | 1989-07-11 | 1998-06-16 | Gen-Probe Incorporated | Methods of amplifying nucleic acids using promoter-containing primer sequence |
| US7009041B1 (en) | 1989-07-11 | 2006-03-07 | Gen-Probe Incorporated | Oligonucleotides for nucleic acid amplification and for the detection of Mycobacterium tuberculosis |
| US5776693A (en) * | 1990-06-08 | 1998-07-07 | Institut Pasteur | Specific detection of the mycobacterium tuberculosis |
| AU666200B2 (en) * | 1992-04-28 | 1996-02-01 | Gen-Probe Incorporated | Nucleic acid process probes to (mycobacterium tuberculosis) |
| CA2135073C (en) * | 1992-05-06 | 2002-11-19 | Daniel L. Kacian | Nucleic acid sequence amplification method, composition and kit |
| GB9301776D0 (en) * | 1993-01-29 | 1993-03-17 | Univ Alberta | Method for detecting genomic variation |
| CA2163393C (en) * | 1994-11-30 | 2003-04-22 | Colleen Marie Nycz | Amplification and detection of mycobacteria nucleic acids |
| US5925518A (en) * | 1995-05-19 | 1999-07-20 | Akzo Nobel N.V. | Nucleic acid primers for amplification of a mycobacteria RNA template |
| US5731150A (en) * | 1995-11-01 | 1998-03-24 | Chiron Diagnostic Corporation | IS6110 based molecular detection of mycobacterium tuberculosis |
| FR2767337B1 (fr) | 1997-08-14 | 2002-07-05 | Pasteur Institut | Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose |
| FR2791067B1 (fr) * | 1999-03-16 | 2003-01-31 | Pasteur Institut | Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins |
| JP4092201B2 (ja) * | 2000-12-26 | 2008-05-28 | タカラバイオ株式会社 | 病原微生物の検出方法 |
| ES2560433T3 (es) | 2004-04-26 | 2016-02-19 | Wako Pure Chemical Industries, Ltd. | Cebadores para la detección del bacilo de la tuberculosis y procedimiento de detección del bacilo de la tuberculosis humana con los mismos |
| CA2621622A1 (en) | 2005-09-05 | 2007-03-15 | Bio-Rad Pasteur | Use of both rd9 and is6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets |
| US20120100545A1 (en) * | 2009-07-03 | 2012-04-26 | Tan Tock Seng Hospital | Method and/or primers for the detection of mycobacterium tuberculosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0460041B2 (en) * | 1989-02-22 | 2004-08-25 | Cogent Limited | Probes, kits and methods for the detection and differentiation of mycobacteria |
| FR2651505B1 (fr) * | 1989-09-06 | 1994-07-22 | Pasteur Institut | Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments. |
-
1990
- 1990-06-08 FR FR9007192A patent/FR2663033B1/fr not_active Expired - Lifetime
-
1991
- 1991-06-07 JP JP91510731A patent/JPH05507617A/ja active Pending
- 1991-06-07 WO PCT/FR1991/000457 patent/WO1991019004A1/fr not_active Ceased
- 1991-06-07 EP EP91401501A patent/EP0461045B1/fr not_active Expired - Lifetime
- 1991-06-07 ES ES91401501T patent/ES2093688T3/es not_active Expired - Lifetime
- 1991-06-07 DE DE69121975T patent/DE69121975T2/de not_active Expired - Lifetime
- 1991-06-07 AT AT91401501T patent/ATE142702T1/de not_active IP Right Cessation
- 1991-06-07 DK DK91401501.1T patent/DK0461045T3/da active
- 1991-06-07 CA CA002084894A patent/CA2084894A1/fr not_active Abandoned
-
1996
- 1996-11-27 GR GR960403179T patent/GR3021781T3/el unknown
-
1997
- 1997-07-26 HK HK97101606A patent/HK1000072A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE142702T1 (de) | 1996-09-15 |
| HK1000072A1 (en) | 1997-11-14 |
| DE69121975D1 (de) | 1996-10-17 |
| DK0461045T3 (enExample) | 1997-02-17 |
| EP0461045A1 (fr) | 1991-12-11 |
| GR3021781T3 (en) | 1997-02-28 |
| FR2663033A1 (fr) | 1991-12-13 |
| EP0461045B1 (fr) | 1996-09-11 |
| WO1991019004A1 (fr) | 1991-12-12 |
| FR2663033B1 (fr) | 1992-09-04 |
| DE69121975T2 (de) | 1997-03-27 |
| ES2093688T3 (es) | 1997-01-01 |
| JPH05507617A (ja) | 1993-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fidler et al. | Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. | |
| CA2084894A1 (fr) | Detection specifique du mycobacterium tuberculosis | |
| Murgia et al. | Oligonucleotides specific for pathogenic and saprophytic leptospira occurring in water | |
| FR2596774A1 (fr) | Sondes oligonucleotidiques et procedes pour la detection par hybridation des acides nucleiques de bacteries et autres etres vivants | |
| JP2010537650A (ja) | 細菌及び真菌の検出方法 | |
| EP0490951B1 (fr) | Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments | |
| WO1995003412A2 (fr) | Fragment nucleotidique de l'arn ribosomique 23s de mycobacteries, sondes et amorces derivees, reactif et procede de detection | |
| Waage et al. | Detection of low numbers of pathogenic Yersinia enterocolitica in environmental water and sewage samples by nested polymerase chain reaction | |
| EP0943010B1 (fr) | Procede de mise en evidence de contaminants microbiologiques vivants dans un echantillon de produit a usage alimentaire | |
| FR2694768A1 (fr) | Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés. | |
| WO1993009251A1 (fr) | Sequences nucleotidiques hybridant specifiquement avec les souches bacteriennes du complexe mycobacterium avium-intracellulare | |
| Souza et al. | Development and evaluation of a single tube nested PCR based approach (STNPCR) for the diagnosis of plague | |
| JP3416981B2 (ja) | 核酸合成法 | |
| JPH10500011A (ja) | 直列変異反復配列オリゴタイピングによる結核菌群細菌の検出および鑑別 | |
| EP0643776B1 (fr) | Sequences nucleotidiques issues de genes codant des pectate-lyases, et leurs utilisations notamment pour la detection de bacteries du genre erwinia | |
| FR2659086A1 (fr) | Fragments nucleotidiques caracteristiques de fragments d'adn de mycobacteries. leur utilisation comme amorce pour la detection d'une infection due a des mycobacteries. | |
| JP5621992B2 (ja) | カンジダ種を検出および同定するための方法 | |
| EP1644526B1 (fr) | Procede de detection et/ou d identification de bacteries de genre staphylococcus | |
| JP5873356B2 (ja) | モニリエラ属真菌の検出方法 | |
| US6787648B2 (en) | Compositions and methods for detecting raphidophytes | |
| EP0828857B1 (fr) | Sonde, sequence nucleiques et procede notamment, de detection et d'identification de levures, de meme que les outils genetiques correspondants | |
| EP0725836B1 (fr) | Sonde et procede de detection des levures de l'espece candida krusei | |
| CA2383003A1 (fr) | Oligonucleotides monocatenaires, sondes, amorces et procede de detection des spirochetes | |
| WO1996000299A1 (fr) | Fragments d'acides nucleiques, derives du genome de mycobacterium xenopi et leurs applications | |
| Masseret et al. | Amplified rDNA Restriction Analysis (ARDRA) for monitoring of potentially toxic cyanobacteria in water samples |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |